Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Pruritus × Aprepitant × Clear all

Phase

Phase 4 1 Phase 2 1 Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 1 Pruritus 1 Nausea 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Breast Neoplasms 1

Interventions

Capsules 1 Aprepitant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06931119 2025-04-17

Aprepitant in the Management of Immune Checkpoint Inhibitors Pruritus in Solid Cancer Patients

Rabin Medical Center

Phase 1 Not yet recruiting

Pruritus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡